~~<i id='01E0A43200'><strike id='01E0A43200'><tt id='01E0A43200'><pre id='01E0A43200'></pre></tt></strike></i>~~

Home» leisure time» knowledge

knowledge

author：fashion 2025-10-02 04:40:29 Page View：512

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moderna says combo Covid
Next article： Guidelines to prevent youth baseball injuries need more muscle

explore

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

MEXICOCITY--NewlyformedHurricaneBeatrizsweptalongMexico’ssouthwesternPacificcoastlateFriday,threaten

Medicare proposal to cover medical devices draws a mixed reaction

AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

Medical device trials still don't enroll enough women, study finds

AdobeWomenhavealwaysbeenunderrepresentedinmedicalresearch.Anewstudyrevealsthatnotmuchhaschanged,espe

WSS

knowledge

knowledge

comprehensive

explore

Medical device trials still don't enroll enough women, study finds